Nicotine pharmacodynamics of a new oral nicotine spray versus NiQuitin lozenges in healthy smokers

Phase 2 trial of nicotine in nicotine dependence (3 arms), sponsored by McNeil Laboratories. Primary endpoints: Area under the urges to smoke versus time curve from start of administration to 5 minutes, Area under the urges to smoke versus time curve from start of administration to 3 minutes and 1 more. Started Nov 2009; status: completed.